These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 1917057)

  • 1. Impact of leukocytes on the storage of platelet concentrates.
    Pietersz RN; de Korte D; Dekker WJ; Reesink HW
    Infusionstherapie; 1991 Jun; 18 Suppl 1():10-2. PubMed ID: 1917057
    [No Abstract]   [Full Text] [Related]  

  • 2. Is leukocyte depletion important in the prevention of alloimmunization by random single donor platelet transfusions?
    Gmür J; Schanz U; Burger J; Reichlin M; Müller E; Oelz O
    Infusionstherapie; 1991 Jun; 18 Suppl 1():13-8. PubMed ID: 1917058
    [No Abstract]   [Full Text] [Related]  

  • 3. Filtration of platelet concentrates.
    Müller N
    Infusionstherapie; 1991 Jun; 18 Suppl 1():19-23. PubMed ID: 1917059
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Technical aspects of buffy coat removal from whole blood and those of platelet production from single buffy coat units.
    Rácz Z; Baróti C
    Biomed Tech (Berl); 1993 Nov; 38(11):266-9. PubMed ID: 8123765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Isolation and use of thrombocyte and leukocyte concentrates].
    Kalinin NN
    Probl Gematol Pereliv Krovi; 1980 Oct; 25(10):50. PubMed ID: 6999495
    [No Abstract]   [Full Text] [Related]  

  • 6. Plateletpheresis with the new COBE Spectra.
    Kretschmer V; Rossa W; Eisenhardt G
    Infusionstherapie; 1991 Jun; 18 Suppl 1():24-8. PubMed ID: 1917060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelet storage lesion: an update on the impact of various leukoreduction processes on the biological response modifiers.
    Seghatchian J
    Transfus Apher Sci; 2006 Feb; 34(1):125-30. PubMed ID: 16376152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sample preparation technique and white cell content influence the detectable levels of growth factors in platelet concentrates.
    Zimmermann R; Arnold D; Strasser E; Ringwald J; Schlegel A; Wiltfang J; Eckstein R
    Vox Sang; 2003 Nov; 85(4):283-9. PubMed ID: 14633254
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platelet concentrates: functional considerations, storage, and quality control.
    Murphy S; Schiffer CA; Katz AJ
    J Clin Apher; 1983; 1(3):185-9. PubMed ID: 6546056
    [No Abstract]   [Full Text] [Related]  

  • 10. Single donor granulocytes and platelets.
    Angela E; Robinson E
    Clin Haematol; 1984 Feb; 13(1):185-216. PubMed ID: 6327131
    [No Abstract]   [Full Text] [Related]  

  • 11. [Prevention of HLA-alloimmunization of recipients of platelet concentrates].
    Kuntz BM; Wollenhaupt HJ; Brüster HT
    Beitr Infusionsther; 1991; 28():209-12. PubMed ID: 1725621
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preparation of random donor leukocyte-poor platelets by cytapheresis.
    Olthuis HP; Stienstra S; Puylaert CE; Verhagen CM; Bär BM
    Transfus Sci; 1993 Apr; 14(2):195-7. PubMed ID: 10148612
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Relationship of state of aggregation with various biochemical parameters--tested on platelet concentrates from buffy coats after 5 days of storage].
    Posch U; Kokelj M; Kostner GM; Lanzer G
    Beitr Infusionsther Transfusionsmed; 1994; 32():78-80. PubMed ID: 9480162
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Automated preparation of platelet concentrates from pooled buffy coats using the Gambro OrbiSac system.
    Gulliksson H; Sjödin A; Sandgren P; Vesterinen M; Larsson S; Diedrich B
    Transfus Apher Sci; 2003 Aug; 29(1):11-2. PubMed ID: 12877886
    [No Abstract]   [Full Text] [Related]  

  • 15. [Thrombocyte preparation from whole blood stores. Data on yield and leukocyte contamination].
    Mayer G; Wernet D; Schnaidt M; Sugg U
    Beitr Infusionther Klin Ernahr; 1986; 15():66-74. PubMed ID: 3753415
    [No Abstract]   [Full Text] [Related]  

  • 16. [Evaluation of platelet quality obtained using conventional methods or from buffy-coat and stored at room temperature].
    Dzieciatkowska A; Fuskiewicz M; Ziemba-Zółowska B; Sabliński J
    Acta Haematol Pol; 1994; 25(2):135-43. PubMed ID: 8067184
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quality of platelet concentrates derived by platelet rich plasma, buffy coat and Apheresis.
    Vasconcelos E; Figueiredo AC; Seghatchian J
    Transfus Apher Sci; 2003 Aug; 29(1):13-6. PubMed ID: 12877887
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preparation and storage of "leukocyte-depleted single donor" platelet concentrate: a step forward in effective haemotherapy.
    Elias MK; de Wolf JT; Blom N; Rijskamp L; Halie RM; Smit Sibinga CT
    J Clin Apher; 1991; 6(3):143-9. PubMed ID: 1787130
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention of cytokine accumulation in platelets obtained with the COBE spectra apheresis system.
    Palmer DS; Aye MT; Dumont L; Dumont D; McCombie N; Giulivi A; Rutherford B; Trudel E; Hashemi-Tavoularis S
    Vox Sang; 1998; 75(2):115-23. PubMed ID: 9784664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determination
    Thuku NW; Shikuku K; Mbugua A
    Pan Afr Med J; 2017; 27():226. PubMed ID: 28979628
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.